Allianz Asset Management GmbH - NOVOCURE LTD ownership

NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 318 filers reported holding NOVOCURE LTD in Q2 2022. The put-call ratio across all filers is 1.26 and the average weighting 0.1%.

Quarter-by-quarter ownership
Allianz Asset Management GmbH ownership history of NOVOCURE LTD
ValueSharesWeighting
Q2 2023$434,796
-65.2%
10,477
-49.6%
0.00%
-50.0%
Q1 2023$1,249,649
-1.5%
20,779
+20.2%
0.00%0.0%
Q4 2022$1,268,295
-17.8%
17,291
-14.9%
0.00%
-33.3%
Q3 2022$1,543,000
-65.2%
20,314
-68.1%
0.00%
-25.0%
Q2 2022$4,429,000
-26.4%
63,729
-12.3%
0.00%0.0%
Q1 2022$6,019,000
-46.2%
72,641
-51.2%
0.00%
-50.0%
Q4 2021$11,192,000
-10.2%
148,980
+38.9%
0.01%
-20.0%
Q3 2021$12,462,000
-70.7%
107,273
-44.0%
0.01%
-72.2%
Q2 2021$42,508,000
+200.1%
191,632
+78.8%
0.04%
+157.1%
Q1 2021$14,165,000
-8.3%
107,166
+20.1%
0.01%
-6.7%
Q4 2020$15,441,000
-31.3%
89,235
-55.8%
0.02%
-42.3%
Q3 2020$22,464,000
+51.8%
201,812
-19.1%
0.03%
+52.9%
Q2 2020$14,801,000
+50.2%
249,592
+70.6%
0.02%
+30.8%
Q1 2020$9,854,000
-20.2%
146,329
-0.1%
0.01%
+18.2%
Q4 2019$12,346,000
-9.5%
146,498
-19.9%
0.01%
-15.4%
Q3 2019$13,646,000
-8.4%
182,987
-22.4%
0.01%
-7.1%
Q2 2019$14,901,000
-11.4%
235,672
-32.5%
0.01%
-17.6%
Q1 2019$16,814,000
+13.6%
349,067
-21.2%
0.02%
+6.2%
Q4 2018$14,803,000
-51.3%
442,887
-23.7%
0.02%
-42.9%
Q3 2018$30,410,000
+39.0%
580,337
-16.9%
0.03%
+33.3%
Q2 2018$21,870,000
+8.1%
698,723
-24.7%
0.02%
+10.5%
Q1 2018$20,231,000
+88.0%
928,025
+74.2%
0.02%
+111.1%
Q4 2017$10,760,000532,7090.01%
Other shareholders
NOVOCURE LTD shareholders Q2 2022
NameSharesValueWeighting ↓
Invus Financial Advisors, LLC 350,884$26,344,0008.01%
HARTLINE INVESTMENT CORP/ 318,109$23,884,0003.27%
Deep Track Capital, LP 550,000$41,294,0002.92%
MORGAN JESS S & CO INC 43,975$3,302,0002.03%
Taylor Frigon Capital Management LLC 46,376$3,482,0001.09%
Darsana Capital Partners LP 258,937$19,441,0000.90%
Private Harbour Investment Management & Counsel, LLC 13,562$1,018,0000.81%
Rhenman & Partners Asset Management AB 120,387$9,610,0000.64%
COURAGE CAPITAL MANAGEMENT LLC 10,000$751,0000.50%
Baillie Gifford 9,615,168$721,906,0000.40%
View complete list of NOVOCURE LTD shareholders